TRANSDERMAL SCOPOLAMINE, ORAL MECLIZINE, AND PLACEBO IN MOTION SICKNESS

被引：26

作者：

DAHL, E

OFFEROHLSEN, D

LILLEVOLD, PE

SANDVIK, L

机构：

[1] DYVI OFFSHORE AS,OSLO,NORWAY

[2] CIBA GEIGY PHARM AS,OSLO,NORWAY

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1984年 / 36卷 / 01期

关键词：

D O I：

10.1038/clpt.1984.148

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：116 / 120

页数：5

共 11 条

[1]

BRAND JJ, 1966, PHARMACOL REV, V18, P895

[2]

CHINN HI, 1956, JAMA-J AM MED ASSOC, V160, P755

[3]

GRAYBIEL A, 1968, AEROSPACE MED, V39, P453

[4]

HANDFORD SW, 1954, J PHARMACOL EXP THER, V111, P447

[5]

MCCAULEY ME, 1979, AVIAT SPACE ENVIR MD, V50, P1108

[6]

OHANLON JF, 1974, AEROSPACE MED, V45, P366

[7]

PRICE N, 1979, CLIN THER, V2, P258

[8] TRANSDERMAL SCOPOLAMINE IN THE PREVENTION OF MOTION SICKNESS AT SEA [J].

PRICE, NM ;

SCHMITT, LG ;

MCGUIRE, J ;

SHAW, JE ;

TROBOUGH, G .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (03) :414-419

[9]

SHAW JE, 1977, CLIN PHARMACOL THER, V21, P117

[10] TRANSDERMAL DRUG ADMINISTRATION - A NUISANCE BECOMES AN OPPORTUNITY [J].

SHAW, JE ;

URQUHART, J .

BRITISH MEDICAL JOURNAL, 1981, 283 (6296) :875-876

← 1 2 →